Results Announcement for the Full Year Ended 31 December

Overview

The report describes Telix's 2024 transformation into a larger global radiopharmaceutical business, with group revenue up 56% to $783.2 million. Its sustainability section reports a 2024 review of material priorities and Board-level oversight of sustainability risks and performance. The company implemented systems to track Scope 1 and Scope 2 emissions using both market- and location-based methods, while noting that establishing a baseline and developing science-based targets are future steps.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 20 February 2025
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services